Human Th17 cells can be induced through head and neck cancer and have a functional impact on HNSCC development
Open Access
- 28 September 2010
- journal article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 103 (8), 1245-1254
- https://doi.org/10.1038/sj.bjc.6605891
Abstract
Background: Methods: Results: Conclusion:Keywords
This publication has 52 references indexed in Scilit:
- Endogenous IL-17 contributes to reduced tumor growth and metastasisPublished by American Society of Hematology ,2009
- IL‐17‐producing γδ T cellsEuropean Journal of Immunology, 2009
- Local IL-21 Promotes the Therapeutic Activity of Effector T cells by Decreasing Regulatory T Cells Within the Tumor MicroenvironmentMolecular Therapy, 2009
- Angiostatic activity of the antitumor cytokine interleukin-21Blood, 2008
- Prostaglandin E2 synergistically with interleukin-23 favors human Th17 expansionBlood, 2008
- Generation and regulation of human CD4 + IL-17-producing T cells in ovarian cancerProceedings of the National Academy of Sciences of the United States of America, 2008
- Diverse cytokine production by NKT cell subsets and identification of an IL-17–producing CD4 − NK1.1 − NKT cell populationProceedings of the National Academy of Sciences of the United States of America, 2008
- Human interleukin 17-producing cells originate from a CD161(+)CD4(+) T cell precursorThe Journal of Experimental Medicine, 2008
- γδ T cells: an important source of IL-17Current Opinion in Immunology, 2008
- Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cellsNature Immunology, 2007